Document is current
Any future updates will be listed below
-
Authors
Tsukamoto, Manabu https://orcid.org/0000-0003-4577-5072
Hamasaki, Takahiko
Okimoto, Nobukazu
Saito, Yoshiyuki
Fujiwara, Saeko
-
Funding
Funding for this research was provided by:
Asahi Kasei Pharma Corporation
- License Information
-
More Information
Article History
Received: 22 February 2025
Accepted: 27 August 2025
First Online: 4 September 2025
Declarations
:
: The study complied with the principles of the Declaration of Helsinki and its amendments. Although informed consent was not obtained, the study used an anonymized dataset and was reviewed and approved by the Institutional Review Board of Asai Dermatology [approval number 2023022001]. The research plan was registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry [UMIN000054784].
: MT has received payments for lectures, including speakers’ bureau fees, from Asahi Kasei Pharma Corporation. MT has received consulting fees from Zimmer Biomet G.K.TH has received lecture fees from Asahi Kasei Pharma Corporation, Amgen K. K., Daiichi-Sankyo Healthcare Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Teijin Pharma Ltd.NO received payments for lectures, including speakers’ bureau fees, from Asahi Kasei Pharma Corporation, Amgen K. K., Daiichi-Sankyo Healthcare Co., Ltd., and Teijin Pharma Ltd.YS is an employee of Datack Inc.SF has received lecture fees from Asahi Kasei Pharma Corporation, Teijin Parma LTD, UCB Japan Co., Ltd., Amgen K.K. and GE Healthcare Japan, and supervision fees from Medical Data Card, Inc.
